BUMETANIDE

Course overview

BUMETANIDE IS FDA APPROVED FOR THE MANAGEMENT OF VARIOUS EDEMATOUS CONDITIONS SECONDARY TO CARDIAC FAILURE, OR HEPATIC OR RENAL DISEASE, INCLUDING THE NEPHROTIC SYNDROME. IT FALLS UNDER THE LOOP DIURETIC CLASS. THIS ACTIVITY REVIEWS THE INDICATIONS, ACTION, AND CONTRAINDICATIONS FOR BUMETANIDE AS A VALUABLE AGENT IN THE TREATMENT AND MANAGEMENT OF VARIOUS EDEMATOUS CONDITIONS SECONDARY TO CARDIAC FAILURE, OR HEPATIC OR RENAL DISEASE. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EFFECTS, AND OTHER KEY FACTORS SUCH AS DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM IN THE TREATMENT AND CARE OF PATIENTS WITH EDEMATOUS CONDITIONS.